These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 30196853)

  • 1. Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.
    Cukras C; Wiley HE; Jeffrey BG; Sen HN; Turriff A; Zeng Y; Vijayasarathy C; Marangoni D; Ziccardi L; Kjellstrom S; Park TK; Hiriyanna S; Wright JF; Colosi P; Wu Z; Bush RA; Wei LL; Sieving PA
    Mol Ther; 2018 Sep; 26(9):2282-2294. PubMed ID: 30196853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
    Vijayasarathy C; Sardar Pasha SPB; Sieving PA
    Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.
    Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA
    Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial.
    Mishra A; Vijayasarathy C; Cukras CA; Wiley HE; Sen HN; Zeng Y; Wei LL; Sieving PA
    Mol Ther; 2021 Jun; 29(6):2030-2040. PubMed ID: 33601057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety evaluation of a recombinant AAV8 vector for X-linked retinoschisis after intravitreal administration in rabbits.
    Marangoni D; Wu Z; Wiley HE; Zeiss CJ; Vijayasarathy C; Zeng Y; Hiriyanna S; Bush RA; Wei LL; Colosi P; Sieving PA
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):202-11. PubMed ID: 25211193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse.
    Park TK; Wu Z; Kjellstrom S; Zeng Y; Bush RA; Sieving PA; Colosi P
    Gene Ther; 2009 Jul; 16(7):916-26. PubMed ID: 19458650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.
    Duan C; Ding C; Sun X; Mao S; Liang Y; Liu X; Ding X; Chen J; Tang S
    Stem Cell Res Ther; 2024 May; 15(1):152. PubMed ID: 38816767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.
    Ou J; Vijayasarathy C; Ziccardi L; Chen S; Zeng Y; Marangoni D; Pope JG; Bush RA; Wu Z; Li W; Sieving PA
    J Clin Invest; 2015 Jul; 125(7):2891-903. PubMed ID: 26098217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.
    Pennesi ME; Yang P; Birch DG; Weng CY; Moore AT; Iannaccone A; Comander JI; Jayasundera T; Chulay J;
    Ophthalmol Retina; 2022 Dec; 6(12):1130-1144. PubMed ID: 35781068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Rescue of X-Linked Retinoschisis Mouse (
    Vijayasarathy C; Zeng Y; Brooks MJ; Fariss RN; Sieving PA
    Hum Gene Ther; 2021 Jul; 32(13-14):667-681. PubMed ID: 33019822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ex vivo gene therapy approach in X-linked retinoschisis.
    Bashar AE; Metcalfe AL; Viringipurampeer IA; Yanai A; Gregory-Evans CY; Gregory-Evans K
    Mol Vis; 2016; 22():718-33. PubMed ID: 27390514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.
    Ye GJ; Conlon T; Erger K; Sonnentag P; Sharma AK; Howard K; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):177-84. PubMed ID: 26390091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS.
    van der Veen I; Heredero Berzal A; Koster C; Ten Asbroek ALMA; Bergen AA; Boon CJF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Delivery of rAAV2-hSyn-hRS1 Results in Retinal Ganglion Cell-Specific Gene Expression and Retinal Improvement in the
    Zheng Y; Xu X; Fan R; Jiang H; Guo Q; Han X; Liu Y; Luo G
    Hum Gene Ther; 2024 May; 35(9-10):342-354. PubMed ID: 38661546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Structure and Gene Therapy Outcome in Retinoschisin-Deficient Mice Assessed by Spectral-Domain Optical Coherence Tomography.
    Zeng Y; Petralia RS; Vijayasarathy C; Wu Z; Hiriyanna S; Song H; Wang YX; Sieving PA; Bush RA
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT277-87. PubMed ID: 27409484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice.
    Marangoni D; Bush RA; Zeng Y; Wei LL; Ziccardi L; Vijayasarathy C; Bartoe JT; Palyada K; Santos M; Hiriyanna S; Wu Z; Colosi P; Sieving PA
    Mol Ther Methods Clin Dev; 2016; 5():16011. PubMed ID: 27626041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
    Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors.
    Vijayasarathy C; Zeng Y; Marangoni D; Dong L; Pan ZH; Simpson EM; Fariss RN; Sieving PA
    Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):8. PubMed ID: 36227606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
    Apaolaza PS; Del Pozo-Rodríguez A; Solinís MA; Rodríguez JM; Friedrich U; Torrecilla J; Weber BH; Rodríguez-Gascón A
    Biomaterials; 2016 Jun; 90():40-9. PubMed ID: 26986855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model.
    Apaolaza PS; Del Pozo-Rodríguez A; Torrecilla J; Rodríguez-Gascón A; Rodríguez JM; Friedrich U; Weber BH; Solinís MA
    J Control Release; 2015 Nov; 217():273-83. PubMed ID: 26400864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.